Journal Report

Minerva Endocrinology

Download PDF
Journal Information
Journal Title
Minerva Endocrinology
Publisher
Edizioni Minerva Medica
ISSN
2724-6507
E-ISSN
2724-6116
Database
SCOPUS
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022
2020
2019
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Impact of hypoglycemic agents on glycemic control and cognitive decline in older adults with type 2 diabetes: real-world evidence on glucagon like peptide 1 receptor agonists
Benedetta DI MARZIO, Giulia GASPARINI, Andrea AMBROSIO et al.
2026-9 Vol. 51 Issue 3
Digital platforms influence users and their eating habits
Giulia GUARINO, Renata BRACALE, Martina INGROSSO et al.
2026-9 Vol. 51 Issue 3
Real-time continuous glucose monitoring with subcutaneously inserted sensor correlates better than subcutaneously implantable sensor with glycated hemoglobin, glycated albumin and fructosamine
Sanja MEDENICA, Roberto NEGRO, Djordje POPOVIC et al.
2026-9 Vol. 51 Issue 3
Gut microbiota and metabolic syndrome in postmenopausal women: a narrative review of mechanisms and dietary recommendations
Sebastián CHAPELA, Julieta LOCATELLI, Melannie TORAL-NORISTZ et al.
2026-9 Vol. 51 Issue 3
Highlights of the July-September 2026 issue
Giovanni VITALE
2026-9 Vol. 51 Issue 3
A review of survodutide: a new dual acting agonist
Meenakshi R. YATHINDRA, Ayush BHATTACHARJEE, Nikhil PUNDIR et al.
2026-9 Vol. 51 Issue 3
Amylin role in glucose homeostasis and β-cell function: a robust justification
Suad H. ALMASOUDI, Hayder M. AL-KURAISHY, Ali I. AL-GAREEB et al.
2026-9 Vol. 51 Issue 3
Genomic mapping of diabetic kidney disease biomarkers and identification of potential inhibitors through virtual screening
Yi LIU, Yu WANG
2026-9 Vol. 51 Issue 3
Obesity-cancer convergence in the destiny of an adipocyte
Natalia MALARA, Antonio AVERSA, Francesco RIVA
2026-9 Vol. 51 Issue 3
Efficacy and safety of oral semaglutide as add-on therapy in poorly controlled type 2 diabetes on background SGLT2 inhibitors: a real-world, multi-center, retrospective, observational study (RYS2)
Maria E. MALIGHETTI, Fabio VESCINI, Maria CARPENTIERI et al.
2026-9 Vol. 51 Issue 3
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 3, 2026 07:59